FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula 
or to any isomer thereof, or mixture of isomers thereof, or pharmaceutically acceptable salt thereof, where R1 represents hydrogen or alkyl; R2 and R3 together form -(CH2)2-, and R2' and R3' represent hydrogen, m equals 1; n equals 1; X represents -O-; and Q represents chroman-2-on-7-yl, which is possibly substituted with one or more substitutes independently selected from a group consisting of halogen, trifluoromethyl, trifluoromethoxy, cyano, hydroxy, amino, nitro, alkoxy, cycloalkoxy, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl and alkynyl. The invention also relates to a pharmaceutical composition, as well as to use of chemical compound in any of paragraphs 1-4.
EFFECT: obtaining novel biologically active compounds having monoamine neuromediator reuptake inhibitory activity.
8 cl, 10 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NEW 8-AZA-BICYCLO[3,2,1]OCTANE DERIVATIVES APPLIED AS MONOAMINE NEUROTRNSMITTER RECAPTURE INHIBITORS | 2004 |
|
RU2344136C2 |
| NOVEL QUINUCLIDINE DERIVATIVES AND THEIR USING | 2003 |
|
RU2323217C2 |
| DERIVATIVE OF 8-AZABICYCLO[3,2,1]OCT-2-ENE, METHODS OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2186780C2 |
| POSITIVE ALLOSTERIC MODULATORS (PAM) | 2010 |
|
RU2561920C2 |
| STEREOISOMER COMPOUNDS AND METHODS OF TREATING GASTROINTESTINAL DISORDERS AND CENTRAL NERVOUS SYSTEM DISORDERS | 2005 |
|
RU2374244C2 |
| IMIDES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE, α, ФHO | 1996 |
|
RU2174512C2 |
| SPECIFIC GLYCOCORTICOSTEROID COMPOUND WITH ANTIINFLAMMATORY EFFECT | 2004 |
|
RU2359973C2 |
| AZABICYCLIC ALKANE DERIVATIVES SUBSTITUTED WITH CONDENSED BICYCLOHETEROCYCLE | 2007 |
|
RU2437884C2 |
| TRIAZOLE DERIVATIVES AS GABA RECEPTOR LIGANDS | 2011 |
|
RU2582337C2 |
| SUBSTITUTED QUINOXALINE-TYPE BRIDGE PIPERIDINE COMPOUNDS AND USE THEREOF | 2009 |
|
RU2500678C2 |
